Red X iconGreen tick iconYellow tick icon

Amy Scott-Thomas

Senior Research Fellow
Laboratory Manager

BSc(Hons)(Otago), PhD(Lincoln)

Email amy.scott-thomas@otago.ac.nz

Research interests

Dr Amy Scott-Thomas is a Senior Research Fellow in the Infection Group at the University of Otago, Christchurch, where she leads a multidisciplinary translational research programme focused on developing innovative diagnostic technologies that improve patient outcomes.

Her research combines molecular microbiology, immunology, and clinical research to develop rapid, non-invasive diagnostic tests for infectious diseases using quantitative PCR (qPCR) and CRISPR-based diagnostics. By developing assays that use readily accessible samples, such as blood and urine, her research aims to enable earlier diagnosis, targeted antimicrobial therapy, and improved antimicrobial stewardship.

Dr Scott-Thomas has been involved with numerous clinical studies investigating pneumonia, bloodstream infections, and sepsis, working in partnership with local clinicians and diagnostic laboratories. Her research spans a broad range of bacterial and fungal pathogens, including Legionella, Kingella kingae and Aspergillus species, alongside other important causes of respiratory and invasive infection. She also leads work on the characterisation of monoclonal antibodies against Aspergillus for their use as diagnostic markers and potential use in vaccine development. Her team also produces EUCAST-compliant antimicrobial susceptibility data to support clinical research and antimicrobial stewardship.

The overarching goal of her research is to transform the diagnosis and management of infectious diseases by delivering rapid, accurate, and clinically applicable diagnostic technologies that enable earlier intervention, improve patient outcomes, and reduce the burden of infectious diseases in New Zealand and internationally.

Publications

Lian, X., Chambers, S. T., Miller, A., Drake, M., Lewis, J. G., Bhatia, M., & Scott-Thomas, A. (2026). Prophylactic effect of monoclonal antibody 1D2 administration in a mouse model of invasive aspergillosis. Journal of Fungi, 12(11), 835. doi: 10.3390/jof12110835 Journal - Research Article

Shahid, A., Scott-Thomas, A., Chambers, S., Miller, A., & Bhatia, M. (2026). Prophylactic ALA administration attenuates liver and lung injury in CLP-induced sepsis in mice through CSE/H2S dependent pathways. International Journal of Molecular Sciences, 27, 9341. doi: 10.3390/ijms27209341 Journal - Research Article

Lian, X., Scott-Thomas, A., Lewis, J. G., Bhatia, M., & Chambers, S. T. (2026). In vitro anti-Aspergillus activity and antifungal interactions of monoclonal antibodies 1D2 and 4E4. Journal of Fungi, 12(7), 523. doi: 10.3390/jof12070523 Journal - Research Article

Jun, H., Alizadeh, H., Chambers, S. T., Slow, S., Hampton, J., Murdoch, D., & Scott-Thomas, A. (2026). Effect of copper spiked potting mix on the emergence and growth of viola and cabbages. HortScience, 61(2), 452-456. doi: 10.21273/HORTSCI19074-25 Journal - Research Article

Shahid, A., Chambers, S., Scott-Thomas, A., Zawari, M., & Bhatia, M. (2026). Anti-inflammatory effects of alpha-lipoic acid modulate cystathionine-γ-lyase expression in RAW 264.7 macrophages. International Journal of Molecular Sciences, 27(2), 949. doi: 10.3390/ijms27020949 Journal - Research Article

Back to top